NextCell Pharma AB (SE0009723125) — research page
SE · se-cm-kg/SSME/SE0009723125 · as of 2026-11-06
Identity and listing
The issuer is NextCell Pharma AB, listed on First North Sweden under ticker SE0009723125, with ISIN SE0009723125 and LEI 549300PBFGB5JYKXGA45. Security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | NextCell Pharma AB | source · 2026-11-06 |
| exchange | First North Sweden | source · 2026-11-06 |
| ticker | SE0009723125 | source · 2026-11-06 |
| ISIN | SE0009723125 | source · 2026-11-06 |
| LEI | 549300PBFGB5JYKXGA45 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 46 filings across 22 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 9 days. The latest filing is dated 2026-10-26, eleven days before the record date of 2026-11-06, and is a Company Announcement. The exchange median cadence gap is 11.0 days, with a median of 21 filings and a median latency of 7 days, across 325 issuers on First North Sweden. Sector peer figures are not on the record for this market.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 46 | 9 | 11 |
| exchange median: First North Sweden (325 issuers) | 21 | 11 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-26 | Company Announcement | Company Announcement | NextCell rapporterar numeriskt gynnsamma resultat hos yngre barn - vuxenstrategin ligger fast |
| 2026-10-26 | Company Announcement | Company Announcement | NextCell reports encouraging numerical results in younger children - strategy for adults remains unchanged |
| 2026-10-19 | Investor News | Investor News | NextCell provides update on timing of ProTrans-Young results |
| 2026-10-19 | Investor News | Investor News | NextCell uppdaterar om tidplanen för resultat från ProTrans-Young |
| 2026-09-28 | Investor News | Investor News | NextCell to present at the INNODIA Symposium during EASD 2026 |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor and its location are not on the record. Auditor changes are not on the record, as the lifecycle type map for this register is not yet in place.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as the lifecycle type map for this register is not yet in place. The issuer is not halted.
Orderability
The outcome is not determinable under rule version acm-68000/se/mifid-ii-product-governance/r1, as the chapter as of 2026-11-04 carries no client categories. No client category is named.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read.
Open research
One openly published research note is on the record, from Redeye dated 2025-07-25.
| date | publisher | note | kind |
|---|---|---|---|
| 2025-07-25 | Redeye | NextCell Pharma Q3 2024/2025: Largely as expected | independent |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage is not sealed for this market. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record start date is not on the record.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/SSME/SE0009723125 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://res.cloudinary.com/redeye/image/upload/v1753424263/article-pdfs/update/nextcell-pharma-q3-2024-2025-largely-as-expected_vcmp43.pdf (open research)
- 10.7
- https://mcp.se-cm-kg.ai/record/SSME/SE0009723125 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0009723125"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:4005032212400601.